HOUSE COMMERCE/HEALTH SUBCOMMITTEE PLANS TO MOVE DEVICE REFORM SEPARATELY FROM PDUFA REAUTHORIZATION; BARTON CONTINUES TO CALL FOR STRICTER FDA REFORM
Executive Summary
The House Commerce/Health Subcommittee appears to have placed medical device-related FDA reform measures on a separate track from drug-related reforms and the Prescription Drug User Fee Act reauthorization.